Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild to moderate COVID-19
Drugs manufacturer from Hyderabad on overdrive HYDERABAD, India, May 25, 2021 /PRNewswire/ — Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting…